NCT03351322View on ClinicalTrials.gov

ENERGI-F701 for Female Hair Loss Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

May 23, 2018

Primary Completion Date

November 29, 2019

Study Completion Date

December 26, 2019

Conditions
Female Pattern BaldnessHair LossAlopecia
Interventions
DRUG

ENERGI-F701

ENERGI-F701 are applied for treatment of hair loss.

DRUG

Regaine

Regaine are applied for treatment of hair loss.

Trial Locations (1)

Unknown

Taipei Veterans General Hospital, Taipei

Sponsors
All Listed Sponsors
collaborator

A2 Healthcare Taiwan Corporation

INDUSTRY

lead

Energenesis Biomedical Co., Ltd.

INDUSTRY